Medical Xpress October 24, 2024
Cleveland Clinic

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication.

The is called PIONEER (Protein-protein InteractiOn iNtErfacE pRediction). Researchers demonstrated PIONEER’s utility by identifying for dozens of cancers and other complex diseases in a recently published Nature Biotechnology article.

Genomic research is key in , but it is not always enough on its own, says Feixiong Cheng, Ph.D., study co-lead author and director of Cleveland Clinic’s Genome Center. When it comes to making medications based on genomic data, the average time between discovering a disease-causing gene and entering clinical trials is 10–15 years.

“In theory, making...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Health System / Hospital, Provider, Technology
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Set Your Team Up to Collaborate with AI Successfully
What’s So Great About Nvidia Blackwell?
Mayo develops new AI tools
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article